Denmark vs Developing regions: Proportion of the target population who received the final dose
Denmark
81.0%
in 2024
Developing regions
26.0%
in 2024
Denmark rank
22nd
Developing regions rank
24th
Proportion of the target population who received the final dose over time
- Denmark
- Developing regions
How they compare
Denmark currently reports 81.0% against 26.0% in Developing regions, a difference of 55.0%.
That makes Denmark's figure about 3.1 times Developing regions's.
Across all 14 years both countries report, Denmark has been ahead every year.
Denmark ranks 22nd and Developing regions ranks 24th of 108 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Developing regions | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.0% | 6.0% | 50.0% | Denmark |
| 2020s | 80.6% | 14.0% | 66.6% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Denmark or Developing regions?
- Denmark, at 81.0% against 26.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Denmark and Developing regions?
- 55.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Developing regions?
- 14 years are reported by both, from 2011 to 2024.
- How do Denmark and Developing regions rank globally for proportion of the target population who received the final dose of?
- Denmark ranks 22nd and Developing regions ranks 24th of 108 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.